Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Lucy B. Palmer (New York, United States of America). Inhaled antibiotics: strengths and fears. International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections

Member's Comments

No comment yet.

Related content which might interest you: Inhaled beta2-agonists in asthma management: an evolving story Source: Breathe 2016; 12: 375-377 Year: 2016 Inhaled antibiotic therapy Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections Year: 2013 Inhaled antibiotics: a new tool? Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009 Inhaled antibiotics in critical care Source: Eur Respir Monogr 2017; 75: 80-96 Year: 2017 Inhaled corticosteroids in preschool asthmatics: are they effective and who benefits most? Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003 Inhaled medication: which device for which patient? Source: Eur Respir Monogr 2015; 69: 213-223 Year: 2015 Inhaled corticosteroids in COPD: a case in favour Source: Eur Respir J 2009; 34: 10-12 Year: 2009 Inhaled antibiotics: an answer to MDR pathogens? Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections Year: 2015 Inhaled corticosteroids in COPD: the case against Source: Eur Respir J 2009; 34: 13-16 Year: 2009 Co-dispensing of inhaled corticosteroids and antibiotics Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs Source: Eur Respir J 2012; 40: 1072-1074 Year: 2012 Inhaled therapies: can they breathe new life into asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Inhaled corticosteroids as a cause of CAP Source: Eur Respir Monogr 2014; 63: 234-242 Year: 2014 Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers Source: Eur Respir J, 55 (5) 2001122; 10.1183/13993003.01122-2020 Year: 2020 Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers Source: Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020 Year: 2020 Inhaled corticosteroids: a controversial add-on treatment in COPD Source: Eur Respir J 2010; 36: 973-974 Year: 2010 Inhaled corticosteroids - widely prescribed in early life despite little data on safety and efficacy Source: Eur Respir J 2001; 18: Suppl. 33, 523s Year: 2001 Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias? Source: Eur Respir J, 53 (2) 1802112; 10.1183/13993003.02112-2018 Year: 2019 Inhaled corticosteroids in stable COPD – international recommendations and reality in Bulgaria Source: International Congress 2017 – COPD management Year: 2017 Inhaled beta2-agonists and death for asthma: can we overcome this risk? Source: Annual Congress 2007 - Effect of long acting beta-agonists on severe asthma exacerbations and asthma-related deaths Year: 2007